Obrindatamab

Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer.
Read more
€0.00 (tax incl.)
Reference:
HY-P99762
Product Details
HY-P99762

Data sheet

Size
Multiple sizes
Reactivity
CD3
CAS
2069959-72-2

Menu

Settings